Atherosclerosis Supplements Journal Citation Rate 2026
1567-5688
eISSN 1878-5050
Elsevier BV
NL
About Atherosclerosis Supplements
Atherosclerosis Supplements (AS) is a peer-reviewed academic journal, published by Elsevier BV in NL, catalogued under ISSN 1567-5688 (e-ISSN 1878-5050). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.00 — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
| ISSN (Print) | 1567-5688 |
|---|---|
| ISSN (Online) | 1878-5050 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Atherosclerosis Supplements is published by Elsevier BV and based in Netherlands.
Atherosclerosis Supplements is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Atherosclerosis Supplements
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.000 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S120256695
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.